J. Versluis, MD PhD

Dr. Jurjen Versluis, MD, PhD is a hematologist in the Department of Hematology at the Erasmus MC Cancer Institute, Rotterdam. He received his MD from the VU University, Amsterdam, and completed training in Internal Medicine and Hematology at the Erasmus MC University in Rotterdam. His clinical focus in Hematology are acute lymphoblastic and myeloid leukemia (ALL/AML), myelodysplastic syndromes (MDS), and allogeneic hematopoietic cell transplantation. He is the deputy director of the hematopoietic cell transplantation program at the Erasmus MC Cancer Institute.

His clinical research is focused on improving outcomes for patients with myeloid malignancies by applying personalized treatment approaches using advanced statistical methodologies.
Both his PhD (obtained in 2017, cum laude) and postdoctoral research (2020/2021) at Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, focused on (1) identifying subgroups of patients who particularly benefit from allogeneic transplantation as a treatment strategy and (2) developing risk models specific to toxicity of acute myeloid leukemia treatment and allogeneic transplantation.

Acute Myeloid Leukemia, Allogeneic Hematopoietic Cell Transplantation, Statistical innovation, Trial design, Outcome prediction

• 2020 – present Internist-Hematologist, Erasmus Medical Center Cancer Institute, Rotterdam, NL;
• 2020 – 2022 Post-doctoral researcher, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Laboratory of Dr. Coleman Lindsley
• 2018 – 2020 Fellow Hematology, Erasmus Medical Center Cancer Institute, NL
• 2014 – 2017 Resident Internal Medicine, Amphia Hospital, Breda and Erasmus Medical Center, NL
• 2013 – 2017 PhD cum laude, Erasmus Medical Center, Rotterdam, NL; department of Hematology. Topic: allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia - a personalized approach; Promotor: Prof. Dr. J.J. Cornelissen. Graduation: September 17, 2017
• 2005 – 2011 Bachelor and Master of Science in Medicine, Medical Doctor, VU University Medical Center, Amsterdam, NL.

Scholar

• 2018-today EBMT (Acute Leukemia Working Party); role: Co-chairman of the statistical data-mining committee
• 2018-today HARMONY Alliance; role: Member of the data analysis team
• 2017-today HOVON/Hematology Statistical Team; role: Head of the statistical team since 2023 (7 full-time employees)

Awards

• 2019 Rene Vogels Stipend
• 2019 Medische Proefondervindelijke Wijsbegeerte voor Steven Hoogendijk Prijs: Best Medical Thesis of the Erasmus University Medical Center 2017-2018.
• 2018 – 2019 European Hematology Association Clinical Research Training in Hematology (CRTH) award.
• 2014 American Society of Hematology Outstanding Abstract Achievement Award
• 2012 American Society of Hematology Abstract Achievement Award winner.

Grants/projects

• 2024 Dynamic Prediction of Measurable Residual Disease in Patients with Newly Diagnosed Multiple Myeloma. Leukemie stichting – PI (€40,000)
• 2024 Erasmus MC Starting Grant – personal grant: PI (€120,000)
• 2020 – 2023 A novel strategy based on dynamic risk assessment for the application of alloSCT as a personalized treatment in elderly AML patients. Daniel den Hoed Fund – personal grant: PI (€250,000)
• 2020 – 2021 Dynamic prediction of outcome for AML patients receiving induction treatment.
  ZonMW Rubicon – personal grant: PI (€67,193)